102 related articles for article (PubMed ID: 15602781)
1. I've heard that a measurement called apo B may be better a predicting heart attacks than LDL cholesterol levels. Should I be tested for apo B?
Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):8. PubMed ID: 15602781
[No Abstract] [Full Text] [Related]
2. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
3. [The apoB/apoA-I ratio is better myocardial infarction marker than lipids].
Walldius G; Angelin B; Eriksson M
Lakartidningen; 2006 Mar 8-14; 103(10):751-2. PubMed ID: 16610201
[No Abstract] [Full Text] [Related]
4. [Total variation of LDL-cholesterol and apolipoprotein B/ Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Coşkun A
Anadolu Kardiyol Derg; 2007 Sep; 7(3):331-2; author reply 332. PubMed ID: 17785232
[No Abstract] [Full Text] [Related]
5. Better heart attack prediction from new cholesterol test? Two simple tests could someday elbow aside, or at least complement, today's standard cholesterol tests.
Harv Heart Lett; 2006 Jun; 16(10):3. PubMed ID: 16791941
[No Abstract] [Full Text] [Related]
6. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
Jungner I; Sniderman AD; Furberg C; Aastveit AH; Holme I; Walldius G
Am J Cardiol; 2006 Apr; 97(7):943-6. PubMed ID: 16563891
[TBL] [Abstract][Full Text] [Related]
7. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of apolipoproteins is better than routinely measured traditional lipids].
Kallner A; Estonius M
Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202
[No Abstract] [Full Text] [Related]
12. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.
Walldius G; Jungner I
Nutr Metab Cardiovasc Dis; 2007 Oct; 17(8):565-71. PubMed ID: 17631989
[TBL] [Abstract][Full Text] [Related]
13. [Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol].
Hayashi T; Hirano T; Shiobara T; Suguro T; Adachi M
Rinsho Byori; 2006 Jun; 54(6):569-75. PubMed ID: 16872005
[TBL] [Abstract][Full Text] [Related]
14. Apolipoproteins A-I and B-markers in coronary risk evaluation.
Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
[TBL] [Abstract][Full Text] [Related]
15. [Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis].
Frey J; Couderc R
Ann Biol Clin (Paris); 1998; 56(5):517-20. PubMed ID: 9769517
[No Abstract] [Full Text] [Related]
16. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
Barter PJ; Ballantyne CM; Carmena R; Castro Cabezas M; Chapman MJ; Couture P; de Graaf J; Durrington PN; Faergeman O; Frohlich J; Furberg CD; Gagne C; Haffner SM; Humphries SE; Jungner I; Krauss RM; Kwiterovich P; Marcovina S; Packard CJ; Pearson TA; Reddy KS; Rosenson R; Sarrafzadegan N; Sniderman AD; Stalenhoef AF; Stein E; Talmud PJ; Tonkin AM; Walldius G; Williams KM
J Intern Med; 2006 Mar; 259(3):247-58. PubMed ID: 16476102
[TBL] [Abstract][Full Text] [Related]
17. I've heard that another form of bad cholesterol has been discovered. What can you tell me about it?
Duke Med Health News; 2011 Nov; 17(11):8. PubMed ID: 22211254
[No Abstract] [Full Text] [Related]
18. Which lipid measures are prognostic indicators of cardiovascular disease in women?
Oettgen P
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):190-1. PubMed ID: 16932280
[No Abstract] [Full Text] [Related]
19. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
[TBL] [Abstract][Full Text] [Related]
20. Beyond cholesterol: a new clue to heart disease.
Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):4-5. PubMed ID: 12703447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
